Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-012286
Filing Date
2022-06-03
Accepted
2022-06-03 16:39:30
Documents
1
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4144
  Complete submission text file 0001567619-22-012286.txt   5541
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 (415) 529-5055
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

EIN.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENTALIS PHARMACEUTICALS, LLC 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Kariuki Enoch (Reporting) CIK: 0001843119 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40604 | Film No.: 22995176